klow peptide stack Vial Klow Peptide Stack: A Researcher's

To test GRX-dependent oxidation of reduced roGFP2, the reaction was started by adding 50 M GSSG

severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique, making use of high throughput technologies as described by CMS-2020-01-R U0004- 2019-nCoV Coronavirus, SARS-CoV-2/2019-nCoV (COVID-19), any technique, multiple types or subtypes (includes all targets), non-CDC, making use of high throughput technologies as described by CMS-2020-01-R G2023: Specimen collection for SARS-CoV-2, any specimen source G2024: Specimen collection for SARS-C0V-2 from an individual in a SNF or by a laboratory on behalf of a Home Health Agency, any specimen source MPC will cover COVID-19 testing and screening services to members with no associated member cost share

10.1046/j.0143-2885.2001.00489.x Int

Grosshans M, Vollmert C, Vollstaedt-Klein S, Nolte I, Schwarz E, Wagner X, Leweke M, Mutschler J, Kiefer F, Bumb JM